| Leslie C Oyama, MD | |
|
9300 Campus Point Drive, La Jolla, CA 92037 | |
| (858) 657-7000 | |
| Not Available |
| Full Name | Leslie C Oyama |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 22 Years |
| Location | 9300 Campus Point Drive, La Jolla, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740374578 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | A96317 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Uc San Diego Health Hillcrest - Hillcrest Med Ctr | San diego, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Regents Of The University Of California | 3577476761 | 1692 |
News Archive
Siemens Healthcare has achieved Complete EHR ONC-ATCB 2011/2012 Certification for Soarian® EHR version 2010, INVISION® EHR version 2010 and MedSeries4® EHR version 2010. These Complete EHRs are 2011/2012 compliant and have been certified by the Certification Commission for Health Information Technology (CCHIT®), an ONC-ATCB, in accordance with the applicable certification criteria for Hospitals adopted by the Secretary of Health and Human Services.
Women who are pregnant or trying to fall pregnant and taking a folic acid supplement may be at risk of reducing their folate benefit through sun exposure, a new QUT study has warned.
Argos Therapeutics today announced the publication of a manuscript in the February edition of Clinical Immunology, detailing positive immune response, safety and manufacturing data for its AGS-004 immunotherapy for HIV. AGS-004 is a product of the Company's Arcelis™ technology, and is a personalized, RNA-loaded dendritic cell-based immunotherapy that is perfectly matched to each patient's unique HIV viral burden. The manuscript details a clinical study in which AGS-004 was evaluated in type-1 HIV-infected adults who were being treated with antiretroviral therapy (ART).
Recently, researchers from Sweden reported population-based, age- and sex-specific background incidence rates of conditions that represent potential COVID-19 vaccine adverse events of special interest (AESI) in the general Swedish population with the help of registered data. This study is published on the medRxiv* preprint server.
Researchers from University Hospitals (UH) Case Medical Center's Seidman Cancer Center will present findings from a study that found the presence of tumor-infiltrating lymphocytes, a type of white blood cell, ahead of treatment may help predict response to platinum-based chemotherapy in women with triple-negative breast cancer.
› Verified 6 days ago
| Entity Name | Regents Of The University Of California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376646869 PECOS PAC ID: 3577476761 Enrollment ID: O20031112000695 |
News Archive
Siemens Healthcare has achieved Complete EHR ONC-ATCB 2011/2012 Certification for Soarian® EHR version 2010, INVISION® EHR version 2010 and MedSeries4® EHR version 2010. These Complete EHRs are 2011/2012 compliant and have been certified by the Certification Commission for Health Information Technology (CCHIT®), an ONC-ATCB, in accordance with the applicable certification criteria for Hospitals adopted by the Secretary of Health and Human Services.
Women who are pregnant or trying to fall pregnant and taking a folic acid supplement may be at risk of reducing their folate benefit through sun exposure, a new QUT study has warned.
Argos Therapeutics today announced the publication of a manuscript in the February edition of Clinical Immunology, detailing positive immune response, safety and manufacturing data for its AGS-004 immunotherapy for HIV. AGS-004 is a product of the Company's Arcelis™ technology, and is a personalized, RNA-loaded dendritic cell-based immunotherapy that is perfectly matched to each patient's unique HIV viral burden. The manuscript details a clinical study in which AGS-004 was evaluated in type-1 HIV-infected adults who were being treated with antiretroviral therapy (ART).
Recently, researchers from Sweden reported population-based, age- and sex-specific background incidence rates of conditions that represent potential COVID-19 vaccine adverse events of special interest (AESI) in the general Swedish population with the help of registered data. This study is published on the medRxiv* preprint server.
Researchers from University Hospitals (UH) Case Medical Center's Seidman Cancer Center will present findings from a study that found the presence of tumor-infiltrating lymphocytes, a type of white blood cell, ahead of treatment may help predict response to platinum-based chemotherapy in women with triple-negative breast cancer.
› Verified 6 days ago
| Entity Name | Regents Of The University Of California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780870899 PECOS PAC ID: 6406760131 Enrollment ID: O20031117000940 |
News Archive
Siemens Healthcare has achieved Complete EHR ONC-ATCB 2011/2012 Certification for Soarian® EHR version 2010, INVISION® EHR version 2010 and MedSeries4® EHR version 2010. These Complete EHRs are 2011/2012 compliant and have been certified by the Certification Commission for Health Information Technology (CCHIT®), an ONC-ATCB, in accordance with the applicable certification criteria for Hospitals adopted by the Secretary of Health and Human Services.
Women who are pregnant or trying to fall pregnant and taking a folic acid supplement may be at risk of reducing their folate benefit through sun exposure, a new QUT study has warned.
Argos Therapeutics today announced the publication of a manuscript in the February edition of Clinical Immunology, detailing positive immune response, safety and manufacturing data for its AGS-004 immunotherapy for HIV. AGS-004 is a product of the Company's Arcelis™ technology, and is a personalized, RNA-loaded dendritic cell-based immunotherapy that is perfectly matched to each patient's unique HIV viral burden. The manuscript details a clinical study in which AGS-004 was evaluated in type-1 HIV-infected adults who were being treated with antiretroviral therapy (ART).
Recently, researchers from Sweden reported population-based, age- and sex-specific background incidence rates of conditions that represent potential COVID-19 vaccine adverse events of special interest (AESI) in the general Swedish population with the help of registered data. This study is published on the medRxiv* preprint server.
Researchers from University Hospitals (UH) Case Medical Center's Seidman Cancer Center will present findings from a study that found the presence of tumor-infiltrating lymphocytes, a type of white blood cell, ahead of treatment may help predict response to platinum-based chemotherapy in women with triple-negative breast cancer.
› Verified 6 days ago
| Entity Name | Regents Of The University Of California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578672184 PECOS PAC ID: 3577476761 Enrollment ID: O20031211000464 |
News Archive
Siemens Healthcare has achieved Complete EHR ONC-ATCB 2011/2012 Certification for Soarian® EHR version 2010, INVISION® EHR version 2010 and MedSeries4® EHR version 2010. These Complete EHRs are 2011/2012 compliant and have been certified by the Certification Commission for Health Information Technology (CCHIT®), an ONC-ATCB, in accordance with the applicable certification criteria for Hospitals adopted by the Secretary of Health and Human Services.
Women who are pregnant or trying to fall pregnant and taking a folic acid supplement may be at risk of reducing their folate benefit through sun exposure, a new QUT study has warned.
Argos Therapeutics today announced the publication of a manuscript in the February edition of Clinical Immunology, detailing positive immune response, safety and manufacturing data for its AGS-004 immunotherapy for HIV. AGS-004 is a product of the Company's Arcelis™ technology, and is a personalized, RNA-loaded dendritic cell-based immunotherapy that is perfectly matched to each patient's unique HIV viral burden. The manuscript details a clinical study in which AGS-004 was evaluated in type-1 HIV-infected adults who were being treated with antiretroviral therapy (ART).
Recently, researchers from Sweden reported population-based, age- and sex-specific background incidence rates of conditions that represent potential COVID-19 vaccine adverse events of special interest (AESI) in the general Swedish population with the help of registered data. This study is published on the medRxiv* preprint server.
Researchers from University Hospitals (UH) Case Medical Center's Seidman Cancer Center will present findings from a study that found the presence of tumor-infiltrating lymphocytes, a type of white blood cell, ahead of treatment may help predict response to platinum-based chemotherapy in women with triple-negative breast cancer.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Leslie C Oyama, MD File No 54826, Los Angeles, CA 90074-4826 Ph: (888) 486-4380 | Leslie C Oyama, MD 9300 Campus Point Drive, La Jolla, CA 92037 Ph: (858) 657-7000 |
News Archive
Siemens Healthcare has achieved Complete EHR ONC-ATCB 2011/2012 Certification for Soarian® EHR version 2010, INVISION® EHR version 2010 and MedSeries4® EHR version 2010. These Complete EHRs are 2011/2012 compliant and have been certified by the Certification Commission for Health Information Technology (CCHIT®), an ONC-ATCB, in accordance with the applicable certification criteria for Hospitals adopted by the Secretary of Health and Human Services.
Women who are pregnant or trying to fall pregnant and taking a folic acid supplement may be at risk of reducing their folate benefit through sun exposure, a new QUT study has warned.
Argos Therapeutics today announced the publication of a manuscript in the February edition of Clinical Immunology, detailing positive immune response, safety and manufacturing data for its AGS-004 immunotherapy for HIV. AGS-004 is a product of the Company's Arcelis™ technology, and is a personalized, RNA-loaded dendritic cell-based immunotherapy that is perfectly matched to each patient's unique HIV viral burden. The manuscript details a clinical study in which AGS-004 was evaluated in type-1 HIV-infected adults who were being treated with antiretroviral therapy (ART).
Recently, researchers from Sweden reported population-based, age- and sex-specific background incidence rates of conditions that represent potential COVID-19 vaccine adverse events of special interest (AESI) in the general Swedish population with the help of registered data. This study is published on the medRxiv* preprint server.
Researchers from University Hospitals (UH) Case Medical Center's Seidman Cancer Center will present findings from a study that found the presence of tumor-infiltrating lymphocytes, a type of white blood cell, ahead of treatment may help predict response to platinum-based chemotherapy in women with triple-negative breast cancer.
› Verified 6 days ago
Mrs. Susan Elizabeth Mckim, PA-C Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 10666 N Torrey Pines Rd, La Jolla, CA 92037 Phone: 858-554-8646 Fax: 858-554-6271 | |
Dr. Monte Tim Mellon, M.D. M.B.A. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 9888 Genesee Ave, La Jolla, CA 92037 Phone: 858-626-6150 Fax: 858-626-7117 | |
Richard M Obler, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 354 Ricardo Pl, La Jolla, CA 92037 Phone: 858-922-1073 | |
Ian R Grover, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 9300 Campus Point Drive, La Jolla, CA 92037 Phone: 858-657-7000 | |
Ian Reilly, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 9888 Genesee Ave, La Jolla, CA 92037 Phone: 858-354-6049 | |
George R Baehr, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 10710 N Torrey Pines Rd, La Jolla, CA 92037 Phone: 858-554-8638 | |
Sean X Neath, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 9300 Campus Point Dr, La Jolla, CA 92037 Phone: 858-657-7000 |